The Net Margin of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (600613.SS) is 1.95%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | 1.95% |
| 2024-12-31 | 3.47% |